83 related articles for article (PubMed ID: 31935429)
1. Emerging role of GIP and related gut hormones in fertility and PCOS.
Moffett RC; Naughton V
Peptides; 2020 Mar; 125():170233. PubMed ID: 31935429
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study.
McFarlane SI; Mielke MM; Uglialoro A; Keating SM; Holman S; Minkoff H; Crystal HA; Gustafson DR
J Neurol Neurophysiol; 2017 Feb; 8(1):. PubMed ID: 28690913
[TBL] [Abstract][Full Text] [Related]
3. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H; Chiovato L; Nappi RE
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2695-709. PubMed ID: 32442310
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.
Grespan E; Giorgino T; Natali A; Ferrannini E; Mari A
Metabolism; 2021 Jan; 114():154415. PubMed ID: 33137379
[TBL] [Abstract][Full Text] [Related]
5. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
Rizk MG; Thackray VG
J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
[TBL] [Abstract][Full Text] [Related]
6. The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Lyu X; Lyu T; Wang X; Zhu H; Pan H; Wang L; Yang H; Gong F
Int J Endocrinol; 2021; 2021():6616693. PubMed ID: 33679973
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients.
Paravati R; De Mello N; Onyido EK; Francis LW; Brüsehafer K; Younas K; Spencer-Harty S; Conlan RS; Gonzalez D; Margarit L
J Mol Med (Berl); 2020 Dec; 98(12):1713-1725. PubMed ID: 33047155
[TBL] [Abstract][Full Text] [Related]
9. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS.
Shah A; Dodson WC; Kris-Etherton PM; Kunselman AR; Stetter CM; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Sluss PM; Coutifaris C; Dokras A; Legro RS
J Clin Endocrinol Metab; 2021 Jan; 106(1):108-119. PubMed ID: 32968804
[TBL] [Abstract][Full Text] [Related]
10. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
[TBL] [Abstract][Full Text] [Related]
11. Microbiome and PCOS: State-of-Art and Future Aspects.
Giampaolino P; Foreste V; Di Filippo C; Gallo A; Mercorio A; Serafino P; Improda FP; Verrazzo P; Zara G; Buonfantino C; Borgo M; Riemma G; Angelis C; Zizolfi B; Bifulco G; Della Corte L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669557
[TBL] [Abstract][Full Text] [Related]
12. The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence.
Abdalla MA; Deshmukh H; Atkin S; Sathyapalan T
Ther Adv Endocrinol Metab; 2021; 12():2042018821989238. PubMed ID: 33552465
[TBL] [Abstract][Full Text] [Related]
13. Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS.
Hoover SE; Gower BA; Cedillo YE; Chandler-Laney PC; Deemer SE; Goss AM
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2151-e2161. PubMed ID: 33491091
[TBL] [Abstract][Full Text] [Related]
14. Polycystic Ovary Syndrome: A Contemporary Clinical Approach.
Bjekić-Macut J; Vukašin T; Velija-Ašimi Z; Bureković A; Zdravković M; Andrić Z; Branković M; Crevar-Marinović S; Madić T; Stanojlović O; Milutinović DV; Livadas S; Mastorakos G
Curr Pharm Des; 2021; 27(36):3812-3820. PubMed ID: 33463457
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
16. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome.
Abdalla MA; Deshmukh H; Atkin S; Sathyapalan T
Ther Adv Endocrinol Metab; 2020; 11():2042018820938305. PubMed ID: 32670541
[TBL] [Abstract][Full Text] [Related]
17. GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites.
Sun Z; Li P; Wang X; Lai S; Qiu H; Chen Z; Hu S; Yao J; Shen J
Int J Endocrinol; 2020; 2020():1484321. PubMed ID: 32655632
[TBL] [Abstract][Full Text] [Related]
18. A Role for GLP-1 in Treating Hyperphagia and Obesity.
Grill HJ
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32516384
[TBL] [Abstract][Full Text] [Related]
19. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review.
Zhao X; Jiang Y; Xi H; Chen L; Feng X
Geburtshilfe Frauenheilkd; 2020 Feb; 80(2):161-171. PubMed ID: 32109968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
